Letter to Commissioner Katainen on MDR Implementation Deadline
application/pdf
- 188.98 kB
Date:
09/10/2019 Disease Area:
Letter
AdvaMedDx Letter to House on the DISARM Act (H.R. 4100)
application/pdf
- 112.9 kB
Date:
09/10/2019 Disease Area:
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act (S. 1712)
application/pdf
- 237.14 kB
Date:
09/10/2019 Disease Area:
AdvaMedDx/ACLA Led Dx Reg Reform Stakeholders Letter to Hill 5-3-2019
application/pdf
- 105.79 kB
Date:
09/06/2019 Disease Area:
AdvaMedDx Letter to Sen. Alexander and Murray and Rep. Walden and Pallone
application/pdf
- 319.43 kB
Date:
08/08/2018 Disease Area:
Dx Reform Letter
application/pdf
- 246.25 kB
Date:
05/09/2018 Disease Area:
AdvaMedDx Letter To Amazon, Berkshire Hathaway, And JPMorgan On The Value Of Diagnostics
application/pdf
- 212.02 kB
Date:
04/18/2018 Disease Area:
AdvaMedDx Comment Letter CMS-3295-P Changes to Promote Innovation
application/pdf
- 379.34 kB
Date:
09/09/2016 Disease Area:
Clinical Laboratory Coalition Letter to Senate Leadership on Cuts to Medicare's Clinical Laboratory Fee Schedule
application/pdf
- 44.43 kB
Date:
02/26/2014 Disease Area:
Protecting Access to Medicare Act of 2014 (PAMA) Implementation Letter to CMS May 2014
application/pdf
- 151.41 kB
Date:
05/16/2014 Disease Area: